PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatocellular carcinoma |
| Phenotype | |liver disease |
| Sentences | 82 |
| PubMedID- 24838304 | Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase mr imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease. |
| PubMedID- 20818940 | Hepatitis c virus (hcv) infection spreads primarily via contact with infected blood and can establish a persistent infection in 80% of infected individuals, progressively causing chronic liver disease that can lead to hepatocellular carcinoma or end-stage liver disease requiring a transplant. |
| PubMedID- 23905912 | Objectives: the incidence of hepatocellular carcinoma associated with nonalcoholic fatty liver disease is increasing. |
| PubMedID- 23091810 | We investigated whether apoe genotype determines the disease outcome in hepatitis b virus (hbv)-infected individuals, and verified the association between apoe genotype and the occurrence of hepatocellular carcinoma (hcc) in patients with chronic liver diseases of various etiologies. |
| PubMedID- 21569410 | hepatocellular carcinoma (hcc) results from chronic liver disease and is the most common malignancy of the liver [1]. |
| PubMedID- 24313165 | Epigenetic mechanisms play an extensive role in the development of liver cancer (i.e., hepatocellular carcinoma [hcc]) associated with alcoholic liver disease (ald) as well as in liver disease associated with other conditions. |
| PubMedID- 21656309 | Risk factors influencing postoperative outcomes of major hepatic resection of hepatocellular carcinoma for patients with underlying liver diseases. |
| PubMedID- 25560838 | Persistent hcv infection can lead to progressive liver disease with the development of liver cirrhosis and hepatocellular carcinoma, possibly accounting for up to 0.5 million deaths every year. |
| PubMedID- 25744657 | Clinicopathological features of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease. |
| PubMedID- 23190006 | Background and aim: the purpose of this study was to perform a meta-analysis of all available studies of the diagnostic performance of diffusion-weighted imaging (dwi) in the detection of hepatocellular carcinoma (hcc) in patients with chronic liver disease. |
| PubMedID- 22116467 | Loss of retinoid-containing lipid droplets upon hepatic stellate cell (hsc) activation is one of the first events in the development of liver disease leading to hepatocellular carcinoma. |
| PubMedID- 23146507 | Background: liver transplantation (olt) represents the treatment of choice for small hepatocellular carcinomas (hcc) in patients with end-stage liver disease. |
| PubMedID- 24459650 | Hepatic abscess mimicking hepatocellular carcinoma in a patient with alcoholic liver disease. |
| PubMedID- 24809655 | Questions remain about the relationship between type 2 diabetes mellitus (type 2 dm) and the risk of hepatocellular carcinoma (hcc), especially in patients with chronic liver diseases. |
| PubMedID- 22174525 | A 70-year-old man, with h/o chronic liver disease and suspected of hepatocellular carcinoma [serum alpha-fetoprotein (afp) 5024 ng/ml] was subjected to fluorine-18 fluorodeoxyglucose positron emission tomography (f-18 fdg pet)/computed tomography (ct) imaging. |
| PubMedID- 21743215 | Hcv is a major cause of chronic liver disease that may lead to cirrhosis and hepatocellular carcinoma. |
| PubMedID- 22956868 | hepatocellular carcinoma usually occurs in patients with chronic parenchymal liver disease, especially chronic infection with hepatitis b or c virus or cirrhosis.1 the results of treatment are unsatisfactory because hepatocellular carcinoma cannot be diagnosed in its early stages, and symptoms only appear when the disease is advanced. |
| PubMedID- 23905813 | The extended immune clearance phase is associated with liver disease progression, including development of cirrhosis and hepatocellular carcinoma (hcc). |
| PubMedID- 25715363 | Objectives: to determine the usefulness of contrast-enhanced sonography using the perfluorobutane contrast agent sonazoid (daiichi-sankyo, tokyo, japan) for establishing the diagnosis and cellular differentiation of hepatocellular carcinoma in patients with chronic liver disease. |
| PubMedID- 25103596 | Aims: to evaluate the value of spleen and liver apparent diffusion coefficients (adc) in chronic liver disease patients, with and without hepatocellular carcinoma (hcc), and to investigate the use of diffusion-weighted imaging (dwi) in the diagnosis and follow-up of hepatic fibrosis. |
| PubMedID- 24588677 | Purpose: to assess diagnostic performance and imaging features of gadoxetic acid-enhanced magnetic resonance (mr) imaging in small (hepatocellular carcinoma (hcc) detection in patients with chronic liver disease. |
| PubMedID- 20148264 | Purpose: the optimum strategy, hepatic resection (hr) or liver transplantation (lt), for treatment of early hepatocellular carcinoma (hcc) associated with liver diseases of child-pugh a is far from established. |
| PubMedID- 22675639 | Serum afp is a debated but routinely used marker for hepatocellular carcinoma (hcc) in patients with chronic liver disease [5]. |
| PubMedID- 25276280 | Infection by the hcv can cause acute and chronic liver diseases and may lead to cirrhosis, hepatocellular carcinoma or liver failure. |
| PubMedID- 22352098 | Patients enrolled in study were known cases of chronic liver disease and were complicated by development of hepatocellular carcinoma; those having metastasis in liver from any where were excluded. |
| PubMedID- 26182318 | Development of hepatocellular carcinoma (hcc) in patients with autoimmune liver disease is less common than in those with other types of chronic liver disease. |
| PubMedID- 21234351 | Vitamin a supplementation may be considered since vitamin a deficiency results in nyctalopia and dry cornea, and is associated with increased risk of hepatocellular carcinoma in patients with end-stage liver disease [117, 118]. |
| PubMedID- 22175908 | Aim: malignancies that include hepatocellular carcinoma often occurred in patients with chronic liver disease. |
| PubMedID- 23633285 | Purpose: to determine whether the presence of a hypovascular nodule in the liver showing hypointensity on hepatocyte-phase of gadoxetic acid-enhanced magnetic resonance imaging (eob-mri) is a risk factor for hypervascular hepatocellular carcinoma (hcc) in patients with chronic liver disease. |
| PubMedID- 22801423 | Hepatitis c virus (hcv) is the main agent of acute and chronic liver diseases leading to cirrhosis and hepatocellular carcinoma. |
| PubMedID- 24658135 | Exclusion criteria for hcv and hbv patients were: 1) previous treatment with antiviral therapy, immunosuppressive drugs, and/or regular use of drugs influencing lipid metabolism and/or oxidative stress; 2) advanced cirrhosis; 3) hepatocellular carcinoma; 4) other causes of liver disease or mixed etiologies; 5) human immunodeficiency virus infection; 6) active intravenous drug addiction, 7) alcohol consumption. |
| PubMedID- 26052388 | Aim: to evaluate the association between alpha-1 antitrypsin deficiency (a1atd) and hepatocellular carcinoma (hcc) in patients with end-stage liver disease (esld). |
Page: 1 2